Tags

WHO

  • Another Call for Action on the Fight Against AMR

    Last week, the Review on Antimicrobial Resistance, published its final report on Tackling Drug-Resistant Infections Globally. The document represents an important call for action in the global fight against AMR and is expected to have a huge impact on the current debate. Setting the scene, the report states that 700,000 people die of drug-resistant infections…

  • Risk in EU Legislation: The Snake Inside or Outside the Box

    Although risk and hazard are sometimes used interchangeably, they are fundamentally different: anything that can cause harm represents a hazard, whereas risk describes the chance of harm being done – in terms of both the likelihood of harm, and the extent of that harm. To understand this difference is crucial when regulating potentially harmful substances.…

  • How to avoid slipping back to the ‘pre-penicillin era’

     This week the European Parliament adopted its own-initiative Report on Safer Healthcare in Europe: Improving Patient Safety and Fighting Antimicrobial Resistance. With this report MEPs are pointing to a looming global health crisis which requires urgent action on many fronts. In our latest snapshot Kyra Obolensky and Darren Kinsella from FTI Consulting’s healthcare team say…

  • The comeback of forgotten diseases

                      There are many diseases which Europe had presumed to be cured and therefore forgotten. For decades, diseases like polio and tuberculosis (TB) have been associated with developing countries and not those in the EU however recently, we are starting to see a worrying increase in incidents…

Back to top